PMID: 42170981

Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.

Long Wang, Ningning Li, Weijun Huang

Pakistan journal of pharmaceutical sciences · 2026

Vol. 39, Issue 7, pp. 2165-2172

This entry links to third-party literature. For research use only.

HumansGlucagon-Like PeptidesMaleDiabetic NephropathiesFemaleMiddle AgedCanagliflozinDrug Therapy, CombinationDiabetes Mellitus, Type 2Blood Glucose

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.